Stemline Therapeutics
Stemline Therapeutics

Stemline Therapeutics

hand in laptop pointing to email icon

Your dream job…could be 1 update away

Stemline Therapeutics Careers, Jobs, and Salary Information

Find High Paying Jobs and Compensation Information at Stemline Therapeutics

Stemline Therapeutics is a clinical-stage biopharmaceutical company that develops novel oncology therapeutics. The company's lead product candidate, SL-401, is a targeted therapy directed to the interleukin-3 receptor (CD123) present on a variety of hematologic malignancies. SL-401 has demonstrated clinical activity in several indications, including blastic plasmacytoid dendritic cell neoplasm (BPDCN), acute myeloid leukemia (AML), and myeloproliferative neoplasms (MPN). Stemline is also developing a pipeline of other novel oncology therapeutics, including SL-801, a novel oral small molecule reversible inhibitor of XPO1, and SL-701, an immunotherapeutic that targets glioblastoma multiforme (GBM). The company is headquartered in New York, New York.

Snapshot

Employees70
Market Cap$249
5 Year Trendarrow trend up+16430%
stats icon
Total value of jobs:
$824,000
stats icon
Total Jobs:
4
stats icon
Average Pay:
$206,000